CATTLE ENROFLOXACIN (SC) RESOURCES McKellar, Q., Gibson, I., Monteiro, A., & Bregante, M. (1999). Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy, 43(8), 1988–1992. https://doi.org/10.1128/AAC.43.8.1988 Davis, J. L., Foster, D. M., & Papich, M. G. (2007). Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves. Journal of Veterinary Pharmacology and Therapeutics, 30(6), 564–571. https://doi.org/10.1111/j.1365-2885.2007.00914.x Foster, D. M., Martin, L. G., & Papich, M. G. (2016). Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin. PLOS ONE, 11(2), e0149100. https://doi.org/10.1371/journal.pone.0149100 Foster, D. M., Sylvester, H. J., & Papich, M. G. (2017). Comparison of direct sampling and brochoalveolar lavage for determining active drug concentrations in the pulmonary epithelial lining fluid of calves injected with enrofloxacin or tilmicosin. Journal of Veterinary Pharmacology and Therapeutics, 40(6), e45–e53. https://doi.org/10.1111/jvp.12412 RESOURCES Kaartinen, L., Salonen, M., Älli, L., & Pyörälä, S. (1995). Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. Journal of Veterinary Pharmacology and Therapeutics, 18(5), 357–362. https://doi.org/10.1111/j.1365-2885.1995.tb00604.x
